News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
394,067 Results
Type
Article (15477)
Company Profile (116)
Press Release (378474)
Section
Business (121586)
Career Advice (463)
Deals (20773)
Drug Delivery (28)
Drug Development (35681)
Employer Resources (50)
FDA (9729)
Job Trends (8019)
News (190382)
Policy (14506)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1348)
Accelerated approval (2)
Allergies (39)
Alliances (37710)
ALS (24)
Alzheimer's disease (572)
Antibody-drug conjugate (ADC) (65)
Approvals (9769)
Artificial intelligence (227)
Autoimmune disease (2)
Automation (11)
Bankruptcy (136)
Best Places to Work (6708)
BIOSECURE Act (6)
Biosimilars (28)
Biotechnology (91)
Bladder cancer (24)
Brain cancer (12)
Breast cancer (115)
Cancer (1029)
Cardiovascular disease (62)
Career advice (413)
Career pathing (8)
CAR-T (98)
Cell therapy (262)
Cervical cancer (10)
Clinical research (28426)
Collaboration (586)
Compensation (106)
Complete response letters (4)
COVID-19 (1198)
CRISPR (34)
C-suite (136)
Cystic fibrosis (50)
Data (990)
Decentralized trials (1)
Denatured (18)
Depression (16)
Diabetes (95)
Diagnostics (4993)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (79)
Drug pricing (13)
Drug shortages (4)
Duchenne muscular dystrophy (22)
Earnings (42341)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (54463)
Executive appointments (386)
FDA (10370)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (464)
Gene editing (80)
Generative AI (23)
Gene therapy (167)
GLP-1 (234)
Government (1347)
Grass and pollen (2)
Guidances (26)
Healthcare (10256)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (29)
Indications (13)
Infectious disease (1272)
Inflammatory bowel disease (72)
Inflation Reduction Act (3)
Influenza (32)
Intellectual property (60)
Interviews (51)
IPO (8664)
IRA (8)
Job creations (1600)
Job search strategy (369)
Kidney cancer (3)
Labor market (9)
Layoffs (122)
Leadership (3)
Legal (3176)
Liver cancer (39)
Lung cancer (138)
Lymphoma (62)
Machine learning (2)
Management (17)
Manufacturing (169)
MASH (15)
Medical device (11600)
Medtech (11605)
Mergers & acquisitions (12469)
Metabolic disorders (210)
Multiple sclerosis (28)
NASH (3)
Neurodegenerative disease (30)
Neuropsychiatric disorders (3)
Neuroscience (763)
NextGen: Class of 2025 (3607)
Non-profit (1544)
Northern California (1085)
Now hiring (8)
Obesity (93)
Opinion (76)
Ovarian cancer (47)
Pain (48)
Pancreatic cancer (38)
Parkinson's disease (64)
Partnered (13)
Patents (132)
Patient recruitment (50)
Peanut (26)
People (34633)
Pharmaceutical (19)
Phase I (9971)
Phase II (12598)
Phase III (8728)
Pipeline (549)
Podcasts (37)
Policy (27)
Postmarket research (681)
Preclinical (4369)
Press Release (66)
Prostate cancer (42)
Psychedelics (4)
Radiopharmaceuticals (161)
Rare diseases (145)
Real estate (3648)
Recruiting (20)
Regulatory (10813)
Reports (18)
Research institute (1303)
Resumes & cover letters (68)
Rett syndrome (3)
RNA editing (2)
RSV (21)
Schizophrenia (13)
Series A (83)
Series B (48)
Service/supplier (7)
Sickle cell disease (18)
Southern California (1187)
Special edition (1)
Spinal muscular atrophy (61)
Sponsored (13)
Startups (2625)
State (2)
Stomach cancer (2)
Supply chain (24)
The Weekly (18)
United States (11352)
Vaccines (312)
Venture capitalists (19)
Webinars (7)
Weight loss (34)
Women's health (17)
Worklife (2)
Date
Today (59)
Last 7 days (355)
Last 30 days (1466)
Last 365 days (18838)
2025 (4536)
2024 (19942)
2023 (23456)
2022 (32666)
2021 (34451)
2020 (32788)
2019 (27313)
2018 (20655)
2017 (20337)
2016 (19088)
2015 (22301)
2014 (16731)
2013 (14135)
2012 (15237)
2011 (15581)
2010 (14220)
Location
Africa (351)
Alabama (37)
Alaska (6)
Arizona (122)
Arkansas (10)
Asia (33460)
Australia (5030)
California (2838)
Canada (1078)
China (296)
Colorado (156)
Connecticut (133)
Delaware (42)
Europe (54264)
Florida (455)
Georgia (131)
Idaho (33)
Illinois (273)
India (16)
Indiana (153)
Iowa (4)
Japan (112)
Kansas (80)
Kentucky (6)
Louisiana (5)
Maine (23)
Maryland (451)
Massachusetts (2000)
Michigan (180)
Minnesota (248)
Mississippi (2)
Missouri (57)
Montana (24)
Nebraska (15)
Nevada (20)
New Hampshire (66)
New Jersey (946)
New Mexico (16)
New York (845)
North Carolina (523)
North Dakota (7)
Northern California (1085)
Ohio (100)
Oklahoma (11)
Oregon (19)
Pennsylvania (577)
Puerto Rico (7)
Rhode Island (20)
South America (561)
South Carolina (16)
South Dakota (1)
Southern California (1187)
Tennessee (55)
Texas (446)
Utah (101)
Virginia (63)
Washington D.C. (12)
Washington State (318)
West Virginia (3)
Wisconsin (37)
394,067 Results for "covalon technologies ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Covalon Announces Voting Results from Fiscal 2024 Annual Meeting of Shareholders
March 20, 2025
·
3 min read
Press Releases
Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 19, 2025
March 12, 2025
·
4 min read
Business
Covalon Announces Profitable Second Quarter Fiscal 2024 Results
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 second quarter results for the period ended March 31, 2024.
May 29, 2024
·
15 min read
Covalon Presents Compassionate Care Technology at the Infusion Nurses Society (INS) Annual Meeting & Exhibition in Kansas City, MO
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the Infusion Nurses Society Annual Meeting and Exhibition, to be held in Kansas City, Missouri from Saturday, May 18 to Monday, May 20, 2024.
May 17, 2024
·
5 min read
Business
Covalon Technologies Ltd. Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO
Covalon Technologies Ltd. today announced that its Board of Directors (the “ Board ”) has appointed Mr. Brent Ashton to serve as Chief Executive Officer and a director of the Company, effective immediately.
January 4, 2024
·
6 min read
Business
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2024 Financial Results
Covalon Technologies Ltd., an advanced medical technologies company, will release its Q2 Fiscal 2024 financial results on Wednesday, May 29, 2024, before markets open.
May 22, 2024
·
3 min read
Business
Covalon Announces Management Changes
Covalon Technologies Ltd. today announced the following management changes.
January 26, 2024
·
3 min read
Press Releases
Covalon Announces Conference Call to Discuss First Quarter Fiscal 2025 Financial Results
February 14, 2025
·
3 min read
Business
Covalon Announces First Quarter Fiscal 2024 Results
Covalon Technologies Ltd. today announced its fiscal 2024 first quarter results for the period ended December 31, 2023.
February 28, 2024
·
11 min read
Business
Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders
Covalon Technologies Ltd., an advanced medical technologies company, announced the results of the matters voted upon at its Fiscal 2023 Annual Meeting of Shareholders held March 6, 2024.
March 7, 2024
·
4 min read
1 of 39,407
Next
